jorry@lonzeal.com
jorry@lonzeal.com
Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. is a full-industry-chain pharmaceutical company focusing on core therapeutic areas including antiviral, antidepressant, antineuralgic and gastrointestinal products. We integrate the manufacturing of finished dosage forms, APIs, intermediates and R&D. Founded in 2006, the Company has its headquarters and R&D center in Shijiazhuang, and operates three production bases in Hebei and Shandong provinces.
With more than 800 employees, we embrace our philosophy of "Shaping Quality with Professionalism and Dedication" and remain committed to our mission of "Contributing to Health and Better Life."
Lonzeal exports to more than 20 countries and has won China CDC centralized procurement bids for years. As a key global supplier of anti-HIV medicines, we provide stable and reliable drug to 4 million AIDS patients worldwide every year.
Our reliable production ensures high-quality global delivery, contributing to the stability of the global pharmaceutical industry chain and in particular, the HIV/AIDS drug supply.
Talent is the driving force behind our growth. We empower our people without bias or rigid rules. We advance individuals based on capability and performance — not seniority. Opportunities are available for those who are self-driven to accelerate their careers.
Professionalism is the foundation of our success. We are committed to building a high-performing culture driven by deep expertise, a results-driven mindset, and continuous learning.
We uphold strong employment principles and maintain flexible talent systems that adapt to the needs of our people and the business. Our dual career pathways allow employees to grow in both specialized technical roles and leadership positions. Advancement and compensation are based on merit, capability, and performance rather than seniority.
The R&D system comprises Shijiazhuang R&D Center, Technology Research Institute and Process Engineering Research Institute, with a professional team of over 200 researchers. It has been recognized as Provincial Enterprise Technology Center, Class A Provincial Enterprise R&D Institution, Hebei Provincial Technology Innovation Center and Hebei Provincial Engineering Research Center. We maintain stable and in-depth cooperation with numerous well-known universities, enterprises and R&D institutions.
Read More
Lonzeal has established a presence across two national-level industrial platforms. Its production bases are strategically located in Shenze Park of Hebei National Biomedical Industrial Park and Shandong Rizhao National Economic and Technological Development Zone. Supported by the region's highly developed ecosystem of pharmaceutical talent, profound industrial expertise, advanced technologies and robust resources, Lonzeal has built world-class Quality Management and ESG systems aligned with international standards. These high-level industrial capabilities underpin the Company's high-quality and sustainable development.
Read More
"Abiding by Integrity, Crafting Medicines with Dedication" is the core quality philosophy that Lonzeal has always upheld. We apply the utmost rigor throughout the entire lifecycle including R&D, manufacture and supply. Through continuously refined scientific management and a rigorous pursuit of excellence, we consistently strengthen the foundation of pharmaceutical quality. As a global modern pharmaceutical enterprise, we always put responsibility and quality at the core, striving to become a long-trusted value partner in the global healthcare industry.
Read More
After more than ten years of dedicated development and accumulation, the company has established a mature and comprehensive technical platform system, as well as stringent and standardized quality management system and ESG management system.
From process innovation and optimization, product incubation and achievement transformation, to the design of industrialization schemes for registration batches, we provide one-stop integrated services for pharmaceuticals from R&D to industrialization.
Environmental
Social
Governance
We are committed to green and low-carbon development, continuously improving energy efficiency, actively promoting scientific carbon emission reduction targets, and popularizing the application of clean energy to reduce our operational carbon footprint and address global climate change through concrete actions.......
Explore More
We are people-oriented, creating a diverse, equal, inclusive, and respectful workplace environment, effectively protecting the legitimate rights and interests of our employees, improving our career development and training system, focusing on employee health, safety, and well-being, and continuously enhancing employees' sense of belonging and happiness.......
Explore More
We uphold the highest business ethics and legal standards, improve our anti-corruption and anti-unfair competition mechanisms, and maintain open communication with all stakeholders through regular and transparent information disclosure.......
Explore More
CPHI Japan East Halls 1, 2 & 3,Tokyo Big Sight,Tokyo, Japan Opening times 21 April: 10:00-17:00 22 April: 10:00-17:00 23 April: 10:00-17:00...
CPHI Americas Pennsylvania Convention Center, Philadelphia Show hours June 2: 9:00 AM - 5:00 PM (EST) June 3: 9:00 AM - 5:00 PM (EST) June ......
FCE Pharma is the main business platform for the pharmaceutical sector in Latin America and the only fair that covers all stages of the pro......
CPHI & PMEC China is Asia’s premier pharmaceutical event for sourcing, networking, learning and innovation with over 20 years’ experience o......
Date: 2025-07-12 08:00:00 I. Construction Project Name and Summary 1. Project Name: Shijiazhuang Longze Pharmaceutica......
Date: 2025-06-30 09:26:38 I. Project Overview 1. Project Name: Shijiazhuang Longze Pharmaceutical Co., Ltd. Oral Soli......
Date: 2025-06-27 09:24:07 In accordance with the requirements of the Public Participation Measures for Environmental ......
Shijiazhuang Longze Pharmaceutical Co., Ltd. Oral Solid Preparation Workshop Pilot Technical Transformation Project – Public Comment Draft Announceme...
